GCM
RGEN icon

Graham Capital Management’s Repligen RGEN Stock Holding History

Graham Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Sell
2,086
-1,822
-47% -$255K 0.01% 889
2025
Q4 		$640K Buy
3,908
+1,389
+55% +$218K 0.02% 535
2025
Q3 		$337K Buy
+2,519
New +$306K 0.01% 809
2024
Q4 		– Sell
-2,620
Closed -$390K – 1445
2024
Q3 		$390K Sell
2,620
-847
-24% -$121K 0.01% 707
2024
Q2 		$437K Sell
3,467
-799
-19% -$125K 0.01% 624
2024
Q1 		$785K Buy
4,266
+1,137
+36% +$217K 0.01% 485
2023
Q4 		$563K Buy
+3,129
New +$487K 0.01% 563

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Graham Capital Management's RGEN Position: Q1 2026 in Review

Graham Capital Management reduced its Repligen (RGEN) stake by 47% in Q1 2026, selling an estimated $255K and leaving 2,086 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #889.

Graham Capital Management first reported a position in RGEN in Q4 2023 and has held it in 7 quarters since. The position peaked at $785K in Q1 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Graham Capital Management held 2,086 shares of Repligen worth $246K as of Q1 2026.
  • Graham Capital Management sold 1,822 Repligen shares in Q1 2026, an estimated $255K.
  • Repligen made up 0.01% of Graham Capital Management's portfolio in Q1 2026, its #889 holding.
  • Graham Capital Management first reported a position in Repligen in Q4 2023 and has held it in 7 quarters since.
  • Graham Capital Management's Repligen position peaked at $785K in Q1 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.